Results 71 to 80 of about 898 (115)

Approved therapies in the IgA nephropathy armamentarium: a summary of the evidence. [PDF]

Kidney Int Suppl (2011)
Norouzi S, Lafayette RA.
europepmc   +1 more source

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons. [PDF]

Adv Ther
Dixon BP, Bomback AS, Rich C, Hakimi Z, Huang M, Gordon K, Wojciechowski P, Margas W, Chang R, Duh MS, Caravaca-Fontán F, Fakhouri F.   +11 more
europepmc   +1 more source

Design and Rationale of the APPELHUS Phase 3 Open-Label Study of Factor B Inhibitor Iptacopan for Atypical Hemolytic Uremic Syndrome [PDF]

Introduction: Atypical hemolytic uremic syndrome (aHUS) is a rare, progressive, and life-threatening form of thrombotic microangiopathy (TMA) which is caused by dysregulation of the alternative complement pathway (AP).
Dahlke M, Fakhouri F, Charney A, Greenbaum LA, Kavanagh D, Vasudevan S, Chen CW, Bagga A, Karki RJ   +8 more
core  

Efficacy and Safety of Treatments for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review. [PDF]

J Clin Med
Gandhi S, Munro I, Shodimu V, Webb N, Pannagl K, Wiyani A, Balp MM.   +6 more
europepmc   +1 more source

Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports. [PDF]

Clin Kidney J
Zubidat D, Soler MJ, Cara A, Sethi S, Appel GB, Santoriello D, Dos Santos FG, Fervenza FC.   +7 more
europepmc   +1 more source

Beyond Terminal Blockade: A Mechanism-Based Approach to Complement Inhibitor Selection in Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Drug Des Devel Ther
Chen C, Zhong J, Xiong D.
europepmc   +1 more source

Cold agglutinin disease: pathophysiology, diagnosis, and the evolving therapeutic landscape. [PDF]

Blood Res
Choi DH.
europepmc   +1 more source

A Narrative Review of C3 Glomerulopathy: From Pathogenesis to Targeted Therapy. [PDF]

Can J Kidney Health Dis
Jauhal A, Barr B, Girard L, Laurin LP, Wong-Rieger D, Licht C.   +5 more
europepmc   +1 more source

Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease. [PDF]

J Blood Med
Bienz M, Oliver M, Sperlich C, Patriquin CJ.   +3 more
europepmc   +1 more source

C3 Glomerulopathy: recent advances and an update on management. [PDF]

J Bras Nefrol
Palma LMP, Barbosa MINH, Sethi S.
europepmc   +1 more source